Alaunos Therapeutics (TCRT) Revenue & Revenue Breakdown
Alaunos Therapeutics Revenue Highlights
Latest Revenue (Y)
$10.00K
Latest Revenue (Q)
$2.00K
Alaunos Therapeutics Revenue by Period
Alaunos Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $10.00K | 100.00% |
| 2023-12-31 | $5.00K | -99.83% |
| 2022-12-31 | $2.92M | 634.17% |
| 2021-12-31 | $398.00K | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | -100.00% |
| 2018-12-31 | $146.00K | -97.71% |
| 2017-12-31 | $6.39M | -6.88% |
| 2016-12-31 | $6.86M | 58.38% |
| 2015-12-31 | $4.33M | 215.51% |
| 2014-12-31 | $1.37M | 71.63% |
| 2013-12-31 | $800.00K | - |
| 2012-12-31 | $800.00K | 19.94% |
| 2011-12-31 | $667.00K | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2007-12-31 | - | 100.00% |
| 2006-12-31 | - | 100.00% |
| 2005-12-31 | - | 100.00% |
| 2004-12-31 | - | 100.00% |
| 2003-12-31 | - | -100.00% |
| 2002-12-31 | $2.57K | 48.90% |
| 2001-12-31 | $1.73K | - |
Alaunos Therapeutics generated $10.00K in revenue during NA 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Alaunos Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $2.00K | -50.00% |
| 2024-12-31 | $4.00K | 100.00% |
| 2024-09-30 | - | -100.00% |
| 2024-06-30 | $4.00K | 300.00% |
| 2024-03-31 | $1.00K | - |
| 2023-12-31 | $1.00K | 100.00% |
| 2023-09-30 | - | -100.00% |
| 2023-06-30 | $4.00K | 100.00% |
| 2023-03-31 | - | -100.00% |
| 2022-12-31 | $11.00K | -99.62% |
| 2022-09-30 | $2.91M | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | -100.00% |
| 2021-09-30 | $398.00K | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | -100.00% |
| 2018-03-31 | $146.00K | -90.86% |
| 2017-12-31 | $1.60M | -0.06% |
| 2017-09-30 | $1.60M | 0.06% |
| 2017-06-30 | $1.60M | - |
| 2017-03-31 | $1.60M | - |
| 2016-12-31 | $1.60M | -0.06% |
| 2016-09-30 | $1.60M | -5.83% |
| 2016-06-30 | $1.70M | -13.81% |
| 2016-03-31 | $1.97M | 2.61% |
| 2015-12-31 | $1.92M | 2.68% |
| 2015-09-30 | $1.87M | 587.13% |
| 2015-06-30 | $272.00K | - |
| 2015-03-31 | $272.00K | -20.00% |
| 2014-12-31 | $340.00K | -46.29% |
| 2014-09-30 | $633.00K | 216.50% |
| 2014-06-30 | $200.00K | - |
| 2014-03-31 | $200.00K | - |
| 2013-12-31 | $200.00K | - |
| 2013-09-30 | $200.00K | - |
| 2013-06-30 | $200.00K | - |
| 2013-03-31 | $200.00K | - |
| 2012-12-31 | $200.00K | - |
| 2012-09-30 | $200.00K | - |
| 2012-06-30 | $200.00K | - |
| 2012-03-31 | $200.00K | - |
| 2011-12-31 | $200.00K | - |
| 2011-09-30 | $200.00K | - |
| 2011-06-30 | $200.00K | 198.51% |
| 2011-03-31 | $67.00K | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2010-09-30 | - | 100.00% |
| 2010-06-30 | - | 100.00% |
| 2010-03-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2009-09-30 | - | 100.00% |
| 2009-06-30 | - | 100.00% |
| 2009-03-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2008-09-30 | - | 100.00% |
| 2008-06-30 | - | 100.00% |
| 2008-03-31 | - | 100.00% |
| 2007-12-31 | - | - |
Alaunos Therapeutics generated $2.00K in revenue during Q1 2025, up -50.00% compared to the previous quarter, and up 200.00% compared to the same period a year ago.
Alaunos Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| QLGN | Qualigen Therapeutics | $5.20M | - |
| XBIO | Xenetic Biosciences | $2.50M | $589.90K |
| CYCN | Cyclerion Therapeutics | $2.00M | $81.00K |
| ADXN | Addex Therapeutics | $1.61M | $235.00K |
| BCLI | Brainstorm Cell Therapeutics | $849.00K | - |
| TCRT | Alaunos Therapeutics | $10.00K | $2.00K |
| CDIO | Cardio Diagnostics | $2.02K | $940.00 |
| ALZN | Alzamend Neuro | - | - |
| NRSN | NeuroSense Therapeutics | - | - |